Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Telehealth app for alcohol use treatment in adults with bipolar disorder

Tests a telehealth app to help people with bipolar disorder drink less.

Plain-language title generated from the registry record
Registry title: Senyo Health App - Comorbid Alcohol Use Disorder Treatment in Individuals With Bipolar Disorder Using a Telehealth Collaborative Care Platform

Key facts

Where
Rochester, United StatesSee the site

Where in United States

  • Mayo Clinic in RochesterRochester, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Mayo Clinic
Trial code
NCT07556861
Record updated
31 July 2026
Original description
The purpose of this study is to examine the effectiveness of a digital integrated behavioral health (IBH) platform in improving alcohol use outcomes, including treatment retention and substance use frequency and severity in patients with Bipolar Disorder.Read full original descriptionShow less

Senyo Health App - Comorbid Alcohol Use Disorder Treatment in Individuals With Bipolar Disorder Using a Telehealth Collaborative Care Platform

The purpose of this study is to examine the effectiveness of a digital integrated behavioral health (IBH) platform in improving alcohol use outcomes, including treatment retention and substance use frequency and severity in patients with Bipolar Disorder.

Inclusion: Age>=18 years; History of bipolar I disorder, bipolar II disorder, or schizoaffective disorder of the bipolar type. Can be clinical diagnosis; Ability to read, write, and understand English; Minimum DAST (1+) or AUDIT-C score (3+); Access and willingness to use a mobile device for asynchronous (text) and synchronous (video) engagement with care; Eligibility determined by ASAM Assessment as completed by a LADC.

Exclusion: Clinically unstable medical disease; Inability to actively participate in and learn from psychotherapeutic interaction based on clinical evaluation and clinical judgment; Needing a higher level of mental health care as demonstrated by ASAM[36] assessment; - completed by LADC or MD investigators; Already admitted into or about to initiate treatment in another addiction treatment program; Currently attending High School. (can be 18 though); Pregnancy confirmed by self-report; Inability to provide written informed consent; Inability to understand English; Otherwise excluded for administrative reasons and/or clinician judgment.

ClinicalTrials.gov NCT07556861